Brussels, 11/03/2002 (Agence Europe) - Some different shades of opinion were expressed and some points insisted upon in particular, but the High Level Group, formed by Commissioners David Byrne and Erkki Liikanen for identifying ways to promote the competitiveness of the pharmaceuticals industry while developing high health protection standards, gives obvious support to the proposals put forward by the European Commission for reviewing European pharmaceutical legislation. The main...